These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ubiquitin proteasome pathway: implications and advances in cancer therapy. Shah SA, Potter MW, Callery MP. Surg Oncol; 2001; 10(1-2):43-52. PubMed ID: 11719028 [Abstract] [Full Text] [Related]
6. TMC-89A and B, new proteasome inhibitors from streptomyces sp. TC 1087. Koguchi Y, Nishio M, Suzuki S, Takahashi K, Ohnuki T, Komatsubara S. J Antibiot (Tokyo); 2000 Sep; 53(9):967-72. PubMed ID: 11099231 [No Abstract] [Full Text] [Related]
7. The proteasome: a suitable antineoplastic target. Adams J. Nat Rev Cancer; 2004 May; 4(5):349-60. PubMed ID: 15122206 [No Abstract] [Full Text] [Related]
8. The proteasome, a new target for cancer therapy. Gillessen S, Groettup M, Cerny T. Onkologie; 2002 Dec; 25(6):534-9. PubMed ID: 12566898 [Abstract] [Full Text] [Related]
12. Structure-based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome. Furet P, Imbach P, Fuerst P, Lang M, Noorani M, Zimmermann J, García-Echeverría C. Bioorg Med Chem Lett; 2002 May 20; 12(10):1331-4. PubMed ID: 11992770 [Abstract] [Full Text] [Related]
18. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells. Wang J, Sampath A, Raychaudhuri P, Bagchi S. Oncogene; 2001 Aug 02; 20(34):4740-9. PubMed ID: 11498796 [Abstract] [Full Text] [Related]
20. Structure and function of the 20S proteasome and of its regulatory complexes. Lupas A, Zwickl P, Wenzel T, Seemüller E, Baumeister W. Cold Spring Harb Symp Quant Biol; 1995 Aug 02; 60():515-24. PubMed ID: 8824424 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]